<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05797896</url>
  </required_header>
  <id_info>
    <org_study_id>IGS01</org_study_id>
    <nct_id>NCT05797896</nct_id>
  </id_info>
  <brief_title>Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study</brief_title>
  <official_title>A Multicentre, Natural History, Non-interventional Study Evaluating Biomarkers In Participants With Geographic Atrophy(GA) Secondary To Age-Related Macular Degeneration (AMD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complement Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complement Therapeutics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational study to evaluate different biomarkers of subjects with geographic atrophy&#xD;
      secondary to age-related macular degeneration&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, observational study to assess the relationships between circulating levels of&#xD;
      complement proteins measured using the Complement Precision Medicine (CPM) Platform, variants&#xD;
      in genes and lesion progression in subjects with Geographic Atrophy (GA) secondary to&#xD;
      Age-related Macular Degeneration (AMD) over a 12-month period&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 7, 2023</start_date>
  <completion_date type="Anticipated">February 6, 2025</completion_date>
  <primary_completion_date type="Anticipated">February 6, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of complement proteins</measure>
    <time_frame>12 months</time_frame>
    <description>To assess the correlation between circulating levels of complement proteins measured using the Complement Precision Medicine (CPM) Platform and Geographic Atrophy (GA) secondary to Age-related Macular Degeneration (AMD)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CRP Levels</measure>
    <time_frame>12 months</time_frame>
    <description>To observe the influence of any past or concurrent illnesses, in particular inflammation-related illnesses, rise in serum CRP or of any medications on complement profile using the CPM Platform</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geographic Atrophy</measure>
    <time_frame>12 months</time_frame>
    <description>To investigate whether there is a relationship between rate of GA lesion expansion and complement profile measured using the CPM platform</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choroidal Blood Flow</measure>
    <time_frame>12 months</time_frame>
    <description>To investigate the relationship in genes or loci associated with AMD and choroidal blood flow and structure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetics</measure>
    <time_frame>12 months</time_frame>
    <description>To investigate the relationship between variants in genes or loci associated with AMD and the complement profile measured using the CPM platform</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Dry Age-related Macular Degeneration</condition>
  <condition>Geographic Atrophy</condition>
  <condition>Retinal Disease</condition>
  <condition>Macular Degeneration</condition>
  <condition>Macular Atrophy</condition>
  <condition>Retinal Degeneration</condition>
  <condition>Eye Diseases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        250 participants, age 18 years and older, with unilateral or bilateral GA due to AMD will&#xD;
        be accrued.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Clinical diagnosis of GA due to AMD (present in one or both eyes) as confirmed by&#xD;
             fundoscopy and/or any pre-existing retinal imaging at Screening&#xD;
&#xD;
          2. Willing and able to provide written informed consent&#xD;
&#xD;
          3. Male or female aged 18 years and over&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of neovascular (wet) AMD or presence of neovascular (wet) AMD in either eye&#xD;
             confirmed by fundoscopy at screening and/or any pre-existing retinal imaging&#xD;
&#xD;
          2. Any ocular pathology which would impede clear imaging of the macula, e.g. intra-ocular&#xD;
             opacities&#xD;
&#xD;
          3. Macular changes from causes other than AMD&#xD;
&#xD;
          4. Diabetic retinopathy (presence of diabetes with no retinopathy is not an exclusion&#xD;
             criteria) Any physical condition which would prevent the participant from undertaking&#xD;
             the imaging procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Marta Ugarte</last_name>
    <role>Principal Investigator</role>
    <affiliation>Manchester Royal Eye Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marta Ugarte</last_name>
    <phone>0161 701 2589</phone>
    <email>marta.ugarte@mft.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Belfast City Hospital</name>
      <address>
        <city>Belfast</city>
        <zip>BT9 7AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emma McConnell</last_name>
      <phone>(0)28 950 40342</phone>
      <email>e.mcconnell@qub.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bradford Royal Infirmary</name>
      <address>
        <city>Bradford</city>
        <zip>BD9 6TB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Hawes</last_name>
      <phone>01274 27 6376</phone>
      <email>nicola.hawes@bthft.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Frimley Park Hospital</name>
      <address>
        <city>Frimley</city>
        <zip>GU16 7UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jodie Graham</last_name>
      <phone>0300 613 6982</phone>
      <email>jodie.graham6@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gloucestershire Royal Hospital</name>
      <address>
        <city>Gloucester</city>
        <zip>GL1 3NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Lodge</last_name>
      <phone>0300 422 3853</phone>
      <email>Laura.Lodge1@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <zip>LE1 5WW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lauren Rybicki</last_name>
      <phone>07929 873 467</phone>
      <email>lauren.rybicki@uhl-tr.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lindy Gee</last_name>
      <phone>0151 706 3873</phone>
      <email>Lindy.Gee@liverpoolft.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Moorfields Eye Hospital</name>
      <address>
        <city>London</city>
        <zip>EC1V 2PD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Ekani</last_name>
      <phone>02072533411</phone>
      <email>melanie.ekani1@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Eye Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Clarke</last_name>
      <phone>0161 701 2589</phone>
      <email>Stephanie.clarke@mft.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Newcastle Hospital</name>
      <address>
        <city>Newcastle</city>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Myerscough</last_name>
      <phone>0191 28 24820</phone>
      <email>thomas.myerscough@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Renee Cammack</last_name>
      <phone>0115 9249924</phone>
      <email>renee.cammack@nuh.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Smith</last_name>
      <phone>+44 (0)23 8120 6715</phone>
      <email>a.smith@uhs.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sunderland Eye Infirmary</name>
      <address>
        <city>Sunderland</city>
        <zip>SR2 9HP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lauren Gardner</last_name>
      <phone>(0191) 5410175</phone>
      <email>Lauren.Gardner3@nhs.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 22, 2023</study_first_submitted>
  <study_first_submitted_qc>March 22, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>March 22, 2023</last_update_submitted>
  <last_update_submitted_qc>March 22, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Geographic Atrophy</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Retinal Degeneration</mesh_term>
    <mesh_term>Anetoderma</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

